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Abstract 
Bioglan AB is manufacturing a nasal water-in-oil microemulsion that is used to prevent allergic 
reactions in the nose. However some users have reported that the product feels irritating in the nose 
and throat. Another problem with the product is that it is not temperature stable, forming crystals at 
low temperature. Sometimes spontaneous crystallization occurs.   
Therefore a new product has been developed. The aim of the new product is to correct the problems 
with the old product as well as adding another effect. It should moisturize a dry nasal mucosa.  
The main goal of the diploma work is making a physical-chemical characterization of the two 
products and from the results be able to state that the two products are similar enough that no new 
clinical trials have to be performed. 
The characterization was made with a variety of techniques. Differential scanning calorimetry was 
performed to evaluate the temperature stability; Surface tension and spreadability was measured to 
judge the spreading on the nasal mucosa. NMR spectroscopy was performed to elucidate the 
microstructure of the products. Mucoadhesion was measured with a tensile strength experiment. 
The rheological behavior was measured and the phase behavior was briefly studied. 
The products were tested and evaluated by 20 volunteers per product to give more understanding of 
how the products are received and how well the physical chemical properties translated to real use. 
The results indicate the products are similar enough to have the same effect and no new clinical trials 
have to be performed. 
  
 
 
 
Table of contents 
 
Abstract .................................................................................................................................................... i 
Table of contents ......................................................................................................................................ii 
Introduction ............................................................................................................................................. 1 
Theoretical background ........................................................................................................................... 1 
Nasal physiology .................................................................................................................................. 1 
Allergic rhinitis ..................................................................................................................................... 2 
Microemulsions ................................................................................................................................... 2 
Effect of Blox4 Allergy and the need for a new formula ..................................................................... 4 
GMO and PGMO formulation differences ........................................................................................... 5 
Differential scanning calorimetry ........................................................................................................ 6 
Rheology .............................................................................................................................................. 6 
Nuclear magnetic resonance spectroscopy ........................................................................................ 7 
Materials .................................................................................................................................................. 8 
Methods .................................................................................................................................................. 8 
Phase behavior of the formulations .................................................................................................... 8 
DSC measurements ............................................................................................................................. 9 
Water uptake experiment ................................................................................................................. 10 
Rheology ............................................................................................................................................ 10 
Mucoadhesive tensile strength ......................................................................................................... 11 
Surface tension .................................................................................................................................. 12 
Spreadability ...................................................................................................................................... 13 
Water Activity .................................................................................................................................... 13 
NMR spectroscopy - diffusion experiments ...................................................................................... 14 
NMR spectroscopy - phase studies ................................................................................................... 14 
Consumer study ................................................................................................................................. 15 
Results & Discussion .............................................................................................................................. 15 
Phase behavior of the formulations .................................................................................................. 15 
Results from DSC measurements ...................................................................................................... 16 
Surface tension .................................................................................................................................. 20 
 
 
Spreadability ...................................................................................................................................... 22 
Mucoadhesive tensile strength ......................................................................................................... 23 
Rheology ............................................................................................................................................ 24 
Water Activity .................................................................................................................................... 29 
Water uptake experiment ................................................................................................................. 30 
Diffusion NMR spectroscopy of the two formulations...................................................................... 31 
Product behavior on gelatin interface .............................................................................................. 35 
NMR spectroscopy of phase separated layers .................................................................................. 36 
Results from consumer study ............................................................................................................ 41 
Conclusions ............................................................................................................................................ 42 
Future work ........................................................................................................................................... 43 
Acknowledgements ............................................................................................................................... 43 
References ............................................................................................................................................. 43 
Appendix ................................................................................................................................................ 46 
1. DSC run conditions .................................................................................................................... 46 
2. Vegetable oil viscosity measurements ...................................................................................... 47 
3. DSC of different glycerol monooleates ..................................................................................... 51 
4. Consumer study questionnaire ................................................................................................. 55 
5. Assessment of product evaluation answers .............................................................................. 59 
 
1 
 
Introduction  
 
Suffering from allergy is a common health problem. It is estimated that around 15 % of the 
population suffers from pollen allergy alone. Most of these people suffer from nasal symptoms such 
as congestion and rhinitis.  
Another nasal health problem that is especially prevalent among the elderly is having a dry mucosa in 
the nose. This can lead to various symptoms such as irritation, itching and a burning sensation.  
Bioglan AB is manufacturer of a product called Blox4 Allergy. It is a nasal oil formulation that forms a 
protective barrier over the mucosa inside the nose to prevent allergens from causing a reaction 
which would happen if the allergens were to contact the mucosa and elicit a response from the 
immune system [5-7]. 
 The product is classified as a medical device since it contains no active pharmaceutical ingredient. 
The product received some complaints because it was irritating in the nose and throat to some users. 
Another problem was that it was not temperature stable. Crystals could also spontaneously form 
inside the vials.  
Therefore a new product has been developed. It aims to address the problems with the old 
formulation and at the same time also have the ability to moisturize a dry nasal mucosa.  
The main goal of this diploma work is making a physical-chemical characterization of the two 
products and from the results be able to state that the products are similar enough that no new 
clinical trials have to be made. There are no well-defined demands from authorities for this type of 
bridging and for a certain amount of time the new product can be sold without a new set of clinical 
trials. 
Theoretical background 
 
 
Nasal physiology 
The inner parts of the nose are lined with mucosal membranes. The surface of the membranes is 
covered with a sticky water rich material, mucus. The mucus consists of water, glycoproteins, lipids 
and salt. The water content is over 95 %. It is the mucin glycoproteins that give mucus its viscoelastic 
and gel like properties. The mucus catches particles, microorganisms and some gases [8,9].  
There is a synchronized movement of cilia that propels the mucus towards the back of the throat 
were it is swallowed. Most harmful microorganisms and particles are thus hindered from entering 
the lungs. The turnover rate, how long it takes for the mucus to leave the nose once it has been 
secreted, is estimated to be about 10-15 minutes [8,9]. 
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When air is inhaled through the nose it is warmed and moistened. If the nose is exposed to dry and 
hot or cold air it leads to drying up of the mucosal membrane that in normal conditions should be 
moist when contacting the air. If loss of water is too large it causes epithelial damage.  
Anatomical changes in elderly and certain medications can lead to increased risk of suffering from 
dry nose. Some of the symptoms can be: Sensation of dryness, itching, a mild burning sensation, 
nasal obstruction and crusting. The condition can be treated by the application of a protective film to 
the inside of the nose to form a barrier against further contact with dry air. This allows it to heal 
without exposure to mechanical irritation [2]. 
 
Allergic rhinitis 
Allergic rhinitis is a very common condition. Symptoms regularly associated with the disorder are 
sneezing, itching, rhinorrhea and nasal congestion. Oftentimes these symptoms are accompanied 
with conditions in the eyes, throat and ears.  
About 50% of the total amount of rhinitis cases is caused by allergy. The most common allergens are 
pollens, molds, animal dander and dust mites. If a person suffering from allergic rhinitis comes into 
contact with a specific allergen that triggers the immune response of the body, a special type of cells 
called mast cells travel to the surface of the mucosa, where the allergens can be found, and release a 
number of compounds that trigger the allergic response. This is what causes the rhinitis symptoms 
[3]. 
Microemulsions 
The definition of a microemulsion has changed over the years since the term was first introduced. 
Today a microemulsion is defined as an optically isotropic, thermodynamically stable mixture 
containing a hydrophobic compound, a hydrophilic compound and an amphiphilic compound and 
sometimes a cosurfactant. The term is a bit misleading since a microemulsion is not really an 
emulsion. A normal emulsion phase separates if given enough time while a microemulsion is always 
mixed homogeneously since it is thermodynamically stable. Because of the unique properties 
microemulsions exhibit, they are of great interest for use in various pharmaceutical products [4]. 
There are certain proportions of ingredients that enable the microemulsion to be thermodynamically 
stable at a constant temperature. This can be illustrated in a ternary phase diagram. In such a 
diagram there are different areas that correspond to various microstructures that the microemulsion 
can possess. In the most basic ternary phase diagram, like the one below in Figure 1, A,B and C would 
correspond to the hydrophilic, hydrophobic and amphiphilic compounds. 
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Figure 1. Example ternary phase diagram. The composition at a given point is derived by following the lines towards the 
borders [29]. 
 
The three basic structures of a microemulsion are: Oil in water (direct), water in oil (reversed) and 
bicontinuous (L3, V1? or sponge phase).  
Furthermore the amphiphilic molecules will arrange themselves into different structures depending 
on their concentration, to minimize energetically unfavorable interactions. Figure 2 below shows an 
example of the different structures that can appear in a water rich environment. The structures 
depend on the concentrations and temperature of the mixture [31].    
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Figure 2. Illustration of amphiphile aggregation structures at different concentrations and temperatures [30]. 
The structures can be isotropic which means they look the same in all directions like the micellar and 
cubic structures or they can be anisotropic like the hexagonal and lamellar structures. When a 
sample with anisotropic properties is viewed in a microscope with a polarized light source will have a 
distinct texture. 
Effect of Blox4 Allergy and the need for a new formula  
The formulation of Blox4 Allergy is complicated since many demands, some of them a bit 
contradictory, are put on the product. Ideally it should be moisturizing, mucoadhesive, protective 
film forming, temperature stable, low irritating and sprayable.  
The current Blox4 Allergy formulation has a few problems. It is not stable at lower temperatures. It 
has received complaints from users of being irritating inside the nose and throat. Some users also 
report a bad smell and taste of the product.  
There is a constant transportation of mucus from the nose to the throat so the spray film is moved to 
the throat. It is in this stage that some people can detect the taste.    
The product contains humectants that absorb water. This leads to better mucoadhesion and a longer 
duration in the nasal mucosa [34]. Too much water absorption leads to irritation and a burning 
sensation in the nose due to the water being pulled out of the underlying mucosa. 
The product phase separates reversibly in a refrigerator (+5°C). 
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The aim of the new formulation is to address these issues, while still retaining similar properties. The 
old product is called the Glycerol MonoOleate GMO formulation in this report, and the new product 
is called the PolyGlycerolMonoOleate PGMO formulation. The two formulations should be compared 
to verify that the properties are not too dissimilar. This means that no new clinical studies have to be 
made since the products are similar enough to give the same effect. 
The goal of the diploma work is to make a characterization of the formulations and from this verify 
that the products are similar enough to avoid making new clinical trials. 
GMO and PGMO formulation differences 
The ingredients differ somewhat between the GMO and the PGMO formulations.  
An important difference between the two products is that the GMO formulation contains 
glycerolmonooleate (GMO) and the PGMO formulation has polyglycerol monooleate (PGMO) 
instead.  GMO is an amphiphilic molecule with a glycerol group attached to a lipid hydrocarbon 
chain. PGMO instead has several glycerol groups linked in a chain to the same lipid molecule. 
Both formulations contain polysorbate 80, also known as Tween 80. It is a commonly used 
solubilizing agent utilized in a variety of cosmetic and medical products [12]. The other shared 
ingredient is propylene glycol, with the systematic name propane-1,2-diol. It is a viscosity decreasing 
compound that can be used as a solvent. It is a humectant [13]. 
The GMO formulation contains Macrogol 400, which is a generic name for polyethylene glycol. It is 
often used as a solvent or co-solvent [17]. Menthol and eucalyptus are added to improve the taste 
and smell of the product while masking an unpleasant taste and smell that were experienced by 
some users. 
Sesame oil has been exchanged with olive oil. Both oils are similar, with a melting point of -6°C; 
however sesame oil contains a higher percentage of polyunsaturated fats [18].     
To lower the viscosity of the PGMO formulation, MCT oil has been added. MCT stands for medium 
chain triglycerides. It consists of small fatty acids, with 6-12 carbon molecules per hydrocarbon chain.  
GMO Blox4 constituents: 
GMO (Glycerol monooleate) 
Propylene glycol (propane-1,2-diol) 
Macrogol 400 (Polyethylene glycol) 
Sesame oil 
Polysorbate 80 (Tween 80) 
Isotonic water solution 
Menthol  
Eucalyptus 
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PGMO Blox4 constituents: 
MCT oil 
PGMO (Polyglycerol Monooleate) 
Olive oil 
Propylene glycol (propane-1,2-diol) 
Polysorbate 80 (Tween 80)   
Differential scanning calorimetry 
Differential scanning calorimetry (DSC) is a technique that is used to measure energy changes in a 
sample by heating it and recording the energy needed to raise the temperature of it on a thermal 
curve. The required power to heat the sample is then compared to the energy needed to heat an 
inert well defined reference. If the sample undergoes a phase transition or crystallizes, it can be 
detected as a peak in the thermal curve since more or less energy is required to heart the sample 
compared to the reference. The peak can be positive or negative depending on if the transition is 
exothermic or endothermic. The starting point of the peak, where the first crystals are formed is 
defines as the onset of the peak. At the end of the peak, where the last crystals are formed is defined 
as the endset of the peak.  [1]. 
Rheology 
Rheology deals with the flow and deformation properties of a material. If the resistance to flow is 
high when a force is applied to a sample, it corresponds to a high viscosity.  
The groundwork for a mathematical description of rheology was laid by Newton. If the shear stress 
apply is proportional to the shear rate in a linear fashion at every point the fluid is a Newtonian fluid. 
Other relationships between shear stress and shear rate exist. For example if the viscosity of a fluid 
decreases the more force it is affected by it is known as a shear thinning fluid. 
Some pharmaceutical materials are viscoelastic. This means that when stress is applied to a sample 
with this property, some of the energy is dissipating as heat in the viscous flow and some will be 
stored in the material and recovered after the stress has been removed. During a reasonable time 
frame, a perfectly viscous material will have all the energy from the stress converted to heat and no 
deformation will occur. Water is a good example of a material which exhibits this behavior. A 
perfectly elastic material will store all the energy in a structure deformation and will use this energy 
to return to its original structure after the stress is removed. An example of an elastic material is 
rubber. 
The viscoelastic properties of a sample can be described with the storage modulus, G’, that is a 
measurement of how elastic the material is. A higher number means a more elastic material. The loss 
modulus, G’’, is a measure of how viscous the material is. A higher number means a more viscous 
material. The storage modulus and loss modulus are related to each other by the complex shear 
modulus G*. 
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𝐺 ∗=  √𝐺′2 + 𝐺′′2         
Another relationship is the so called loss angle 𝛿. It is given in degrees.  
tan 𝛿 = 𝐺′′/𝐺′ 
A value of 0° means that the material is perfectly elastic and a value of 90° means that it is perfectly 
viscous [10]. 
These properties can be measured by performing an oscillation test. The sample is exposed to a 
sinusoidal oscillation at increasing shear stress and G* is measured as a function of this increasing 
shear stress. As long as G* is constant it means that the structure of the sample is not disturbed and 
the stress applied is in the linear viscoelastic region. It is important to stay in this region when 
performing further measurements, such as varying the oscillation frequency to determine G’, G’’ and 
𝛿 [11]. 
Nuclear magnetic resonance spectroscopy 
Nuclear Magnetic Resonance (NMR) spectroscopy uses the fact that atomic nuclei possess a spin 
magnetic moment. When the nuclei are placed in a strong external magnetic field inside an NMR 
spectrometer, the magnetic moments slightly align with the magnetic field and thus the sample 
becomes magnetized. Thereafter a series of radio frequency pulses excite the samples and cause the 
magnetization vector to move away from equilibrium temporarily. After the pulse, the vector 
precesses back to equilibrium, giving rise to a free induction decay (FID) signal. This signal is 
measured. It can be Fourier transformed and the result is a typical NMR spectrum with peaks that 
correspond to different types of nuclei in the sample [19]. 
With NMR spectroscopy it is possible to measure the self-diffusion constant of a molecule, both in a 
pure sample and in a mixture with other substances. The technique uses a gradient magnetization of 
the sample and a special pulse sequence that disperses and then refocuses the magnetization. 
Depending on where in the sample a molecule is, it will experience a certain strength from the 
magnetic field, due to this gradient. If molecules diffuse it means that they are not in the same 
position as they were at the start of the measurement. When the magnetization is refocused after 
the dispersion, the resulting signal will be weaker than it would have been if all molecules were 
stationary and experienced the same magnetic field as during the start. By varying the gradient 
strength of the magnet, the resulting signal becomes less and less refocused. The gradient strength 
can be plotted versus the signal intensity and an equation can be fitted to the data points, giving the 
diffusion coefficient [19,20-23]. 
𝐼 =  𝐼0 ∗ 𝑒
−𝐷(2𝜋𝛾𝐺𝑖𝛿)
2∗(Δ−
𝛿
3)∗10
4
 
 
Where 𝐼 and 𝐼0 are intensities, 𝛾is the gyromagnetic ratio, Δ and 𝛿 are delay times, 𝐺𝑖  is the gradient 
strength and 𝐷 is the diffusion constant. 
Sometimes there are several compounds beneath the same peak in the NMR spectrum. It is still 
often possible to determine the self-diffusion constants of the molecules. In these cases a 
multiexponential fit is made to the equation:  
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𝐼 =  𝐼01 ∗ 𝑒
−𝐷1(2𝜋𝛾𝐺𝑖𝛿)
2∗(Δ−
𝛿
3
)∗104
 + 𝐼02 ∗ 𝑒
−𝐷2(2𝜋𝛾𝐺𝑖𝛿)
2∗(Δ−
𝛿
3
)∗104
 
A size comparison between 𝐼01 and 𝐼02 gives some information about how much of each type of 
molecule is part of the sample.  
If the water in the sample is enclosed in micelles it will not have the usual self-diffusion coefficient of 
2.299 *10-9 m2/s [26]. Instead it will be an order of magnitude larger due to the entrapment inside 
the micelles. 
With NMR spectroscopy it is possible to detect what type of structure is in a liquid crystalline sample. 
By observing the peak of added deuterium in a 2H NMR spectrum and noting the splitting of the peak 
it is possible to determine if the sample has isotropic phases, anisotropic phases or a mixture of both. 
A 2H nucleus has a strong quadropolar moment, which can lead to a splitting of the peak in the 
spectrum. In an isotropic environment the interactions from the quadropolar moment is averaged 
out to zero and only one peak is observed [27,28].    
Materials 
 
Both formulations were obtained from Bioglan AB, that had made test solutions for use in lab work. 
Mucin from porcine stomach type II (CAS number 84082-64-4) was obtained from Sigma-Aldrich. 
Propylene Glycol was obtained from BASF, lot. S002531.  
Olive oil was obtained from Gustav Heess, lot. GHM-0569. 
Sesame oil was obtained from Henry Lamotte Oils. 
MCT Oil was obtained from R2 Pharmactive, lot. S001960. 
PGMO was obtained from Hydrior. 
Gelatine was obtained from Tørsleffs, bought from a normal grocery store. 
GMO was obtained from Danisco, batch no. 4011742134 
A few different types of PGMO were also used, called PGMO1, PGMO2 PGMO2g, PGMO3 and 
PGMO4.      
Methods 
 
Phase behavior of the formulations 
The phase behavior of the formulations was investigated at different temperatures and water 
content to determine the stability of the product at lower temperatures and at different water 
content. The initial water content of the formulations was determined by using Karl Fisher titration 
on a Metrohm 701 KF Titrino that was calibrated with Hydranal composite 5 and controlled with 
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sodium tartrate dehydrate. The tests were done in duplicates. The results were an initial amount of 
5.16 % of water in the GMO formulation and 0.45 % in the PGMO one. 
Nine vials with 3.0 g of the GMO were prepared. The water content was varied from 5.16 % to 9.16 % 
since the starting concentration of water was 5.16 %, with an increment of 0.5 percentage points 
each time.  
The vials were stirred to allow the water to homogeneously spread out and mix properly with the 
microemulsion. They were put in a water bath (Julabo FS18, manufacturing number 15904360008, 
with HP Basis heating circulators, manufacturing number 17603320091) at 40°C and were left for one 
hour to allow the temperature of the vials to equilibrate with the bath. The same procedure was 
repeated for the temperatures 37°C, 35°C, 30°C and 25°C. The temperatures 20°C, 15°C and 10°C 
were done in another water bath since the Julabo FS18 required extra cooling pipes to run at these 
temperatures. The new water bath was cooled by a Huber ministat 240. The bath itself contained no 
internal thermometer.  
When the Julabo FS18 bath was at 25°C an external uncalibrated thermometer measured 25.4°C. The 
same thermometer measured 20.2°C in the bath cooled by the Huber ministat 240 when the 
temperature set for the water in the cooling pipes was set to 19.4°C. 
The samples were quickly taken from the water bath to maintain the temperature. Then they were 
shaken and visually inspected.  
The PGMO formulation was mixed with water to produce samples with 4.45 %, 6.0 %, 7.0 %, 8.0 %, 
10.0 % and 12.0 % water content. The vials were inspected at 40°C, 35°C, 30°C and 25°C using the 
same Julabo FS18 water bath, and at 20°C, 15°C and 10°C with the same Huber ministat 240. All the 
GMO and PGMO samples were also put in a refrigerator (5°C).    
DSC measurements 
First DSC mesasurements were made on the GMO and PGMO formulations to detect the peak at the 
highest temperature. The endset temperature of this peak gives some information on how 
temperature stable the sample is. 
The DSC apparatus was a Perkin Elmer DSC 7 with Pyris version 3.03 software. It was controlled and 
calibrated each day with a reference sample of indium. The run should fulfill the requirements of an 
onset of 156.60 +/- 0.5 °C (melting point) and a ΔH of 28.45 +/- 0.20 J/g. Nitrogen gas was supplied at 
2 bar pressure which corresponds to about 20 mL/min of flow to the sample compartment during all 
the measurements. 
The samples for the DSC tests were weighed up on a calibrated Sartorius 23607401 scale and put into 
40 µl BO14-3021 aluminum pans that were hermetically sealed with 0.1 mm BO14-3003 aluminum 
lids. The DSC chamber held room temperature when the pans were inserted. The samples were run 
with a program of first holding for 2 minutes at +40°C, then cooling to -40°C and finally reheating to 
+40°C. The cooling and heating rates were 1, 5 and 10 degrees. Duplicates were made for each run.  
According to unpublished work by Soma Ghosh and Johan Engblom, Malmö University, there might 
be an overlapping of peaks if the temperature program going from +40°C to -40°C was used. Because 
of this a new set of measurements were made. These DSC measurements were started at +40°C with 
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a cooldown to -50°C where the temperature was held for ten minutes, after which it was raised back 
to +40°C. These new experiments were done on a Seiko instruments Exstar DSC6200 with the 
software Muse 7.0 U. The samples were weighed on a Cahn C-30 microbalance. Two measurements 
were made with both formulations to check if peaks were overlapping, one at 5°C/min and one at 
1°C/min. 
Another set of measurements was made on different types of Glycerol monooleates. They were 
performed on the Perkin Elmer DSC 7. Details can be found in appendix 1. 
Water uptake experiment  
To produce an atmosphere with a well-defined relative humidity a saturated salt solution can be 
used. A saturated solution with Potassium carbonate was put in an exicator to give a relative 
humidity of 43.16 % at 25°C. Another exicator was prepared with a saturated salt solution of 
potassium sulfate, giving a relative humidity of 97.30 %RH at 25°C [15]. A beaker of each Blox4 
formulation was put in both exicators and left for 53 days.  After 18 and 53 days the amount of water 
that the formulation had absorbed into the beakers was measured.    
 
Figure 3. Picture of one of the exicators with the formulations in beakers inside. 
 
Rheology 
The rheology measurements were done on a Bohlin VOR rheometer. 
The geometry was a C14 concentric cylinder with about 2 ml of sample to fill the sample cup, a gap of 
0.15 mm and a measurement slit of 0.7 mm. All measurements were performed at 25°C. 
First a 3.8 g cm torsion bar was used and a strain sweep from 0.0018  to 0.1946 s-1 was made to 
determine the linear viscoelastic region of both formulations by monitoring the G* value during the 
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sweep. The frequency was set to 10 Hz since the fluids seemed to have a low viscosity upon visual 
inspection. 
With the same torsion bar a frequency sweep was performed from 10 Hz to 0.1 Hz to determine G’, 
G’’ and the loss angle.  
Afterwards viscosity measurements on the formulations were performed with the same torsion bar. 
The shear rate was varied from 0.00927-233.2 s-1.  
Thereafter a high strain rate test was done with the 19 g cm torsion bar for the GMO formulation 
from 9.29-1470 s-1 and the same was done with the PGMO formulation. However at 1470 s-1 the 
measurement was stopped because of overload. The torsion bar was changed to 38.7 g cm and it 
allowed the full range to be measured. At all the measurements of the high shear rate, the value of 
46.4 s-1 was avoided since it corresponded to the resonance frequency of the measurement system. 
To get values that could be compared to the viscosities of the formulations, measurements were 
made on MCT oil, sesame oil, olive oil and PGMO. The measurements were divided into the same 
shear rate intervals as the Blox4 Allergy formulations. The low shear rate measurements for olive oil, 
MCT oil and sesame oil were made with a 3.8 g cm torsion bar and the high with a 19 g cm torsion 
bar. Since PGMO had a much higher viscosity, the low shear rate measurement was done with the 19 
g cm torsion bar and the high with the 270 g cm torsion bar.   
Mucoadhesive tensile strength 
The method for measuring mucoadhesion was based on the method described in [24]. 
The mucoadhesive properties of the formulations were tested on a Stable Micro Systems TA-XT2i 
texture analyzer with a 36 mm diameter probe.  
A dispersion of 4 wt % mucin and 96 wt % deionized water was mixed and heated to 30-35°C under 
stirring until it became homogenous.  
Circular bits of filter papers with an inert backside were cut out to match the area of the probe. One 
paper was put on the probe and another one on the corresponding contact surface area below inside 
a petri dish using double-sided sticky tape. The top paper was smeared with 250 μl of the mucin 
dispersion in a thin smooth layer. The bottom paper was smeared with 250 μl of the Blox4 Allergy 
microemulsion. The papers were then left to soak and dry for 10 minutes before measurements 
began. 
In the measurements, the probe was lowered with a speed of 1 mm/second until a force of 250 g 
was applied to the bottom sample. The force was applied for 180 seconds before detachment and 
measurement of the required force to separate the paper with mucus dispersion from the paper with 
Blox4 microemulsion. The petri dish was fastened on the bottom surface with double-sided sticky 
tape to hinder it from following the probe back up. 
Another set of tests were made with the formulations and pure water to determine if the mucin had 
a special impact on adhesion. 
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To get some reference values, the mucoadhesion of olive oil, propylene glycol and PGMO were also 
tested. Propylene glycol was chosen to determine if humectant properties had any influence on the 
adhesion strength. 
 
 
Figure 4. The texture analyzer with the parts for the tensile strength test assembled. 
Surface tension 
Surface tension comes from a less favorable interaction at an interface between a liquid and another 
material such as the one between water and air. A liquid will minimize its surface area to maintain as 
much of its internal more energetically favorable interactions as possible. The surface tension values 
give some information about how well the product will wet a specific surface, such as the hydrophilic 
mucosa inside the nose [33]. 
The surface tension of the two formulations was measured on a Tecklis Tracker tensiometer with 
Windrop for Windows XP as software.  
All the beakers used were washed in beforehand in a mixture of sulfuric and hydrochloric acid 
(concentration?) to remove any contaminations such as surfactant residues. The needle of the 
syringe used to create the drop was washed with ethanol to prevent wetting of the liquids. The 
temperature was 24°C on the water calibration measurements and 25°C for the measurements on 
the formulations.  
In the Milli-Q water calibration, two sets of 15 µl drops were formed and the surface tension was 
measured for 600 seconds. 
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When the two formulations were tested, the volumes of the drops were 6 µl. The density values used 
were 1.01 kg/dm3 for the GMO formulation and 0.960 kg/dm3 for the PGMO formulation.  
Spreadability 
A glass surface was put in a mixture of sulfuric and hydrochloric acid (concentration again?) for 1.5 
hours, washed with deionized water and allowed to air dry. The glass surface thus becomes 
hydrophilic and can somewhat mimic the conditions of the nasal mucosa. The glass was put on a 
surface that was checked with a spirit level to be straight. 
100 µl of sample was put on the plate and measured after spreading out for 30 minutes. The GMO 
formulation and PGMO formulation were each tested four times. The diameter of the drop on the 
plate was measured with a Vernier caliper.  
Then the plate was washed with detergent and water, allowed to air dry and then put into the same 
bath of sulfuric and hydrochloric acid for 1.5 hours. It was allowed to air dry before 100 µl of 
deionized water and olive oil were put on the surface. Both the deionized water and the olive oil 
were tested four times in the same way as the two formulations.  
 
Figure 5. 100 µl of each formulation was put on a glass plate. 
   
Water Activity 
Water activities of the formulations were measured on a Novasina Labmaster-aw at Malmö 
Högskola. The samples were measured at 25°C with a redox filter to protect the sensor from 
propylene glycol. A measurement was made on the 5.16 % water content GMO formulation and on a 
sample of the PGMO formulation with water added to give 5.16 % total water content. 
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Figure 6. The Novasina Labmaster-aw on which water activity measurements were made. 
NMR spectroscopy - diffusion experiments 
A sample of the PGMO formulation was mixed with water to give 3 % water content in total to keep 
it within the same region in the phase diagram. Disposable NMR tubes were filled with 300 µl of this 
mixture, the GMO formulation and pure PGMO. The PGMO was very viscous and had to stand 
overnight for the sample to settle at the bottom of the NMR tube.  
The chemical shift scale was corrected with deuterated DMSO at 2.5 ppm, together with propylene 
glycol since it was present in both formulations. This was done on a Varian UNITY Inova 500 MHz, 
with the software VnmrJ 3.2.  
Thereafter a total spectrum on both formulations was acquired. A PGSE type diffusion measurement 
was done on both formulations. Since the PMGO formulation had a lesser amount of excipients, its 
constituents were studied in diffusion experiments one by one to confirm that the water peak did 
not have too much of other compounds underneath at its chemical shift value. The exact value of 
water’s chemical shift varies with temperature, pH and constituents of the sample. The peak should 
appear somewhere around 4.7 ppm [32]. 
The data was processed with the program DOSY Toolbox version 2.5 [25]. 
NMR spectroscopy - phase studies 
A vial of each formulation was mixed with an equal amount of water inside a vial. It was allowed to 
phase separate for 5 days before the two phases that formed were put in separate vials at 4000 rpm 
for three hours, removing any residual content from the other phases from the vial. 
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540 µl of each of the four samples were put in NMR tubes and 60 µl of deuterated water was added 
to give a D2O concentration of 10 % by weight, shortly before taking a 
1H and a 2H spectrum of each 
sample on a Varian Unity Nova 500 MHz spectrometer at 298 K. 
The PGMO bottom phase was also studied in a microscope under a polarized light to see if the phase 
showed any sign of anisotropic structures (Why this one?). 
Consumer study 
40 participants were given a questionnaire, which can be found in appendix 4, together with either a 
vial of the GMO formulation or the PGMO formulation. 20 people were given the GMO formulation 
and 20 people were given the PGMO formulation. The two formulations did not have the same type 
of pump for the vials. The GMO formulation had a one-hole pump and the PGMO formulation had a 
five-hole pump that spread the beam shot into smaller segments to achieve a less intense feeling 
when applying the product in the nose. Under supervision the participants were asked to test the 
product and fill in the questionnaire about how they experienced it. The answers were then 
collected, evaluated and scored in a series of diagrams, which can be found in appendix 5.   
Results & Discussion 
 
Phase behavior of the formulations 
The results of the phase behavior study can be seen in Table 1 below. Phase separation means that 
an oil rich phase is forming at the bottom of the vial.  
Table 1. Phase behavior for the GMO formulation at different water contents in percentage of total weight. ps = phase 
separated.  
5°C 10°C 15°C 20°C 25°C 30°C 35°C 37°C 40°C 
5.16 % ps   5.16 %  5.16 %  5.16 %  5.16 %  5.16 %  5.16 %  5.16 %  5.16 %  
5.66 % ps  5.66 % 5.66 % 5.66 % 5.66 % 5.66 % 5.66 % 5.66 % 5.66 % 
6.16 % ps 6.16 % ps 6.16 %  6.16 %  6.16 %  6.16 %  6.16 %  6.16 %  6.16 %  
6.66 % ps  6.66 % ps  6.66 % ps  6.66 % ps  6.66 %   6.66 %   6.66 %   6.66 %   6.66 %   
7.16 % ps 7.16 % ps 7.16 % ps 7.16 % ps 7.16 % ps 7.16 % ps 7.16 %  7.16 %  7.16 %  
7.66% ps 7.66% ps 7.66% ps 7.66% ps 7.66% ps 7.66% ps 7.66% ps 7.66% ps 7.66% ps 
8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 8.16 % ps 
8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 8.66 % ps 
9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 9.16 % ps 
 
Phase separation in the GMO formulation was easy to notice since the liquid became turbid when 
shaken if phase separation had occurred. Phase separation in the PGMO formulation was not as easy 
to detect due to it having a higher viscosity and therefore not responding as much upon shaking.The 
GMO formulation phase separated at lower water content the lower the temperature. At 10°C even 
the 6.16 % water content sample was turbid. The original sample contains 5.16 % of water and phase 
separated at a typical refrigerator temperature of 5°C, after standing for several days even becoming 
completely solid. 
The PGMO formulation with 4.45 % water content was stable at all temperatures. The 6 % water 
content sample was clear and in one phase at 25°C. At 20°C a small new phase was visible at the 
bottom of the vial.    
16 
 
Table 2. Phase behavior for the PGMO formulation at different water contents in percentage of total weight. ps = phase 
separated. 
5°C 10°C 15°C 20°C 25°C 30°C 35°C 37°C 40°C 
5.16 %  5.16 % 5.16 % 5.16 % 5.16 % 5.16 % 5.16 % 5.16 % 5.16 % 
6.0 % ps 6.0 % ps 6.0 % ps 6.0 % ps 6.0 % 6.0 % 6.0 % 6.0 % 6.0 % 
7.0 % ps 7.0 % ps 7.0 % ps 7.0 % ps 7.0 % ps 7.0 % 7.0 % 7.0 % 7.0 % 
8.0 % ps 8.0 % ps 8.0 % ps  8.0 % ps 8.0 % ps 8.0 %  8.0 % 8.0 % 8.0 % 
10.0 % ps 10.0 % ps 10.0 % ps 10.0 % ps  10.0 % ps 10.0 % ps 10.0 % ps 10.0 % ps 10.0 % ps 
12 .0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 12.0 % ps 
 
The results indicate that the PGMO formulation, which is manufactured without containing water 
still can handle about as much water content as the GMO formulation without phase separating. 
 
Results from DSC measurements 
Below are example figures that show the heat flow as a function of time for some measurements. For 
the experiments done on the Perkin Elmer DSC at Bioglan AB, an upwards peak for the heating part 
of the measurement corresponds to an endothermic event. The peak of interest is the last peak 
found when reheating of the sample. 
 
 
Figure 7. Plot of DSC data for the GMO formulation with a scan rate of 10°C/min, done at Bioglan AB. 
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Figure 8. Plot of DSC data for the PGMO formulation with a scan rate of 10°C/min, done at Bioglan AB. 
 
The average endset temperature of this peak was calculated for the different scan rates and 
extrapolated to zero scan rate. The mean extrapolated endset temperature was 10.789°C for the 
GMO formulation and -13.303°C for the PGMO formulation. 
 
 
Figure 9. The endset temperature as a function of scan rate for the GMO formulation. Norm of residuals = 0.17541. 
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Figure 10. The endset temperature as a function of scan rate for the PGMO formulation. Norm of residuals = 0.27251. 
There was a risk of peaks overlapping so a rerun was made with a cooldown to -50 °C with the 
samples holding this temperature for 10 minutes before going back up to 40°C to verify that the 
results were correct. The result is showed in the graphs below. There seemed to be no overlapping 
for the peak of interest. In these experiments, a downwards pointing peak corresponds to an 
endothermic event in the sample if the temperature is in the rising part of the measurement. 
 
Figure 11. Plot of DSC data for the GMO formulation with a scan rate of 5°C/min, done at LTH. 
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Figure 12. Plot of DSC data for the GMO formulation with a scan rate of 1°C/min, done at LTH. 
 
 
 
 
Figure 13. Plot of DSC data for the PGMO formulation with a scan rate of 5°C/min, done at LTH. 
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Figure 14. Plot of DSC data for the PGMO formulation with a scan rate of 1°C/min, done at LTH. 
 
The results indicate that the PGMO formulation is much less sensitive to temperature changes. It will 
not phase separate and form crystals in the same degree as the GMO formulation does. This is 
probably linked to the PGMO. At room temperature it is liquid. GMO on the other hand is solid and 
quite hard. 
Surface tension 
The GMO formulation had a surface tension of 29.4 +/-  0.2 mN/m and the PGMO formulation had a 
surface tension of 29.7 +/- 0.1 mN/m. 
This can be compared to some values from the literature. Mueloliva extra virgin olive oil has a 
surface tension of 28.499 mN/m at 26.94°C and pure sesame oil from Zhangxingbang has a surface 
tension of 28.106 mN/m at 28.31°C [14].  Pure water has a surface tension of 71.99 mN/m at 25°C. 
Propylene glycol has a surface tension of 45.6 mN/m at 25°C [16].  
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Figure 15. Graph showing the surface tension of the PGMO formulation over 600 seconds. 
 
 
Figure 16. Graph showing the surface tension of the PGMO formulation over 600 seconds. 
 
The results are very similar for the two formulations. The values are close to pure olive oil or sesame 
oil and much lower than water. This indicates that spreadability of the PGMO formulation should be 
similar to the GMO formulation. 
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Spreadability 
The mean diameter of the four 100 µl drops from the spreadability testing were: 
23.2 +/- 2.3 mm for the GMO formulation 
19.6 +/- 0.5 mm for the PGMO formulation 
11.9 +/- 0.3 mm for the deionized water 
15.3 +/- 0.4 mm for the olive oil 
The GMO formulation was observed to spread significantly faster than the PGMO formulation within 
the first 10 seconds after applying the product. The PGMO formulation probably spreads more slowly 
partly because of its higher viscosity value. 
Despite having the same surface tension the PGMO formulation shows slightly less spreadability on a 
hydrophilic surface. The values are still fairly similar compared to the values for water and olive oil. 
Water does not spread much despite being put on a hydrophilic surface due to the high surface 
tension of water. However the result might have been affected by some of the water evaporating 
during the 30 minutes. 
Olive oil is very hydrophobic and does not spread well on a hydrophilic surface, despite having a low 
surface tension. 
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Mucoadhesive tensile strength 
Figure 17 below illustrates how the work needed to separate the layers from each other is calculated 
as well as the peak measured force. 
 
Figure 17. The figure shows the force applied as a function of time. The work needed to separate the layers from each 
other is the area calculated from integration of the negative peak. The maximum negative force is the minimum value of 
the negative peak. 
Both the GMO and the PGMO formulations showed quite strong mucoadhesion, with similar tensile 
strength values. Compared to adhesion to pure water it was higher as well.     
The comparison results on olive oil and propylene glycol showed significantly lower values than the 
two formulations. PGMO is intrinsically very sticky and attaches strongly to most surfaces.  
Table 3. Summary of the results from the mucoadhesion measurements. 
Upper sample Lower sample Mucoadhesion (kg s) Peak force (kg) 
Mucin GMO formulation 0.18 +/- 0.18 0.89 +/- 0.11 
Mucin PGMO formulation 0.21 +/- 0.16 0.88 +/- 0.21 
Water GMO formulation 0.067 +/- 0.033 0.65 +/- 0.24 
Water PGMO formulation 0.090 +/- 0.034 0.76 +/- 0.20 
Water Water 0.017 +/- 0.00 0.12+/- 0.011 
Mucin Olive oil 0.089 +/- 0.016 0.79 +/- 0.14 
Mucin Propylene Glycol 0.051 +/- 0.0089 0.50 +/- 0.051 
Mucin PGMO 0.75 +/- 0.31 2.4 +/- 0.26 
Dry paper Dry paper 0 0.006 
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There is a large fluctuation in the values which leads to a high uncertainty. A better method for 
measuring mucoadhesion would be desirable. The results seem conclusive however. The PGMO 
formulation has a value that is a little bit higher. This could be linked to the viscosity which is also 
higher, or that it contains PGMO which is so sticky in itself.   
Rheology 
The strain sweep measurements showed initial fluctuations probably due to insufficient sensitivity in 
the torsion bar and thereafter a linear response, indicating that if the products show any viscoelastic 
behavior the whole measured shear rate is in the linear viscoelastic region. From this data, the 
maximum available shear rate was chosen (0.1946 s-1) since this probably gave the most accurate 
measurements. 
 
Figure 18. The shear rate was varied at a constant frequency of 10 Hz to determine the viscoelastic region of the GMO 
formulation. 
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Figure 19. The shear rate was varied at a constant frequency of 10 Hz to determine the viscoelastic region of the PGMO 
formulation. 
The determination of the storage and loss modules as well as the phase angle showed that both 
formulations had an almost ideal viscous behavior, showing almost no elastic properties.  
 
Figure 20. Frequency sweep of the GMO formulation. At all times the loss module is significantly higher than the storage 
module indicating a viscous behavior. 
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Figure 21. Frequency sweep of the PGMO formulation. At all times the loss module is significantly higher than the 
storage module indicating a viscous behavior. 
The phase angles for the GMO and PGMO formulations were 87.6014° and 88.0459° respectively 
indicating an almost completely ideal viscous behavior. 
The results from the Blox4 allergy viscosity measurements are presented in the figures below. The 
PGMO formulation had a higher viscosity at all times compared to the GMO one. Both formulations 
display a Newtonian behavior. 
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Figure 22. The figure shows the viscosity of the GMO formulation as a function of shear rate at low shear rates. 
 
 
Figure 23. The figure shows the viscosity of the PGMO formulation as a function of shear rate at low shear rates. 
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Figure 24. The figure shows the viscosity of the GMO formulation as a function of shear rate at high shear rates. 
 
Figure 25. The figure shows the viscosity of the PGMO formulation as a function of shear rate at high shear rates. 
 
The plots of viscosity values for the vegetable oils can be found in the appendix. 
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Table X below contains a summary of the apparent viscosity at 116.8 s-1 shear rate. Both Blox4 
formulations have a higher value than for example olive oil. The PGMO formulation has a significantly 
higher value than the GMO one however both values are eclipsed by the value of PGMO. 
Table 4. Summary of apparent viscosities at 116.8 s-1 shear rate. 
Substance Viscosity (Pas) 
MCT oil 0.0203 
Sesame oil 0.0514 
Olive oil 0.0599 
PGMO 4.497 
GMO formulation 0.1085 
PGMO formulation 0.1768 
 
The higher value for the PGMO formulation seems positive in the sense that the product does not 
drip out of the nostrils as easily as the GMO formulation. A disadvantage though is that it makes the 
pump more difficult to initially get started. 
Water Activity 
The water activity was 0.365 for the GMO formulation at a water content of 5.16 % and 0.562 for the 
PGMO formulation with the same water content. This is relative to pure water which has an activity 
of 1.0. The results indicate that the GMO formulation has less free water available at the surface 
when both formulations have the same water content. However the water activity for the PGMO 
formulation at 0.45 % water content was 0.072. 
Having too high water activity in the product can potentially lead to decomposition of the olive oil or 
sesame oil in the product due to microbial activity, which is highly affected by water activity. 
A low water activity also means that the water is more tightly bound to the sample. Having a low 
water activity might lead to a higher water uptake, resulting in a slight burning sensation as water is 
pulled from the underlying tissue when the product is applied. 
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Water uptake experiment 
The initial and final weights of the contents in the beakers is summarized in table 5 and 6 below: 
Table 5. Summary of water uptake of the GMO sample. 
GMO formulation 43.16 %RH 97.30 %RH Relative increase 
43.16 %RH 
Relative increase 
97.30 %RH 
Initial weight 7.073 g 8.775 g - - 
Weight after 18 days 7.145 g 9.981 g 1.0 % 13.7 % 
Weight after 53 days 7.074 g 11.003 g 0 % 25.4 % 
 
Table 6. Summary of water uptake of the PGMO sample. 
PGMO formulation 43.16 %RH 97.30 %RH Relative increase 
43.16 % RH  
Relative increase 
97.30 %RH 
Initial weight 7.495 g 10.002 g - - 
Weight after 18 days 7.572 g 10.764 g 1.0% 7.6 % 
Weight after 53 days 7.518 g 11.111 g 0.3 % 11.1 % 
 
Both formulations absorbed a large amount of water into the beaker at 97.30 %RH. The 
microemulsions phase separated in both beakers into two phases. One on top of the other with a 
clear separation. This was apparent already at the first weighing after 18 days. However this did not 
stop the formulations from keeping to absorb water. The GMO formulations seemed to pull more 
water into the beaker compared to the PGMO formulation. 
A liquid that is hypertonic can cause a burning sensation when applied in the nose since it pulls water 
from the tissue. The PGMO formulation seems to pull a lesser amount of water into the beaker and 
should therefore be less prone to pull water out of the nasal mucosa.     
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Diffusion NMR spectroscopy of the two formulations 
The 1H spectra of the GMO formulation, the PGMO formulation and all the parts of the PGMO 
formulation are presented below. 
 
Figure 26. NMR spectrum of GMO formulation. 
 
Figure 27. NMR spectrum of PGMO formulation. 
In figure 28 below, at 4 to 6 ppm, the smeared out signal indicates that the PGMO sample contains 
various different compounds.  
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Figure 28. NMR spectrum of PGMO. 
 
Figure 29. NMR spectrum of olive oil. 
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Figure 30. NMR spectrum of MCT oil. 
 
Figure 31. NMR spectrum of propylene glycol. 
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Figure 32. NMR spectrum of polysorbate 80. 
The diffusion constants were calculated for each significant peak in each sample. When several 
compounds appeared to be found within the same peak a biexponential fit with two different 
diffusion constants was made. Example figures with an equation fitted to the measured points can be 
found below. 
 
Figure 33. Exponential fit to the first peak at 2.045 ppm in the olive oil sample. An exponential equation with a single 
diffusion coefficient gives a good fit to the data points in this case. This is because olive oil contains molecules of the 
same size. 
 
35 
 
 
Figure 34. The PGMO sample seems to include various different compounds and a better fit is achieved with a 
biexponential equation. 
  
When derived self-diffusion coefficients were evaluated for every significant peak in each sample it 
was found that no compound had a diffusion coefficient that was not an order of magnitude bigger 
than 2.299 *10-9 m2/s. Thus it is highly probable that the structure of the sample is not bicontinuous. 
Since the samples are isotropic the structures where the water is encapsueld are probably micelles.  
Product behavior on gelatin interface 
If the product was put on a gelatin surface, which is water rich, the product phase separated into two 
layers, one water rich and one oil rich layer. This somewhat resembles the conditions on the nasal 
mucosa.  
If the GMO formulation is mixed with water, the temperature rises within the sample, as the GMO 
precipitates out of the solution. 
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Figure 35. The formulations phase separates when put in a gelatine surface. A water rich phase forms closest the the 
gelatine surface and an oil rich phase floats on top. 
 
NMR spectroscopy of phase separated layers 
The 1H spectra are presented in the Figures below: 
 
Figure 36. The figure shows a 1H NMR spectrum of the hydrophobic top phase of the GMO formulation. 
37 
 
 
Figure 37. NMR spectrum of the hydrophilic bottom phase of the GMO formulation. The water peak at 4.7 ppm has been 
cut off. 
 
Figure 38. The figure shows a 
1
H NMR spectrum of the hydrophobic top phase of the PGMO formulation. 
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Figure 39. The figure shows a 
1
H NMR spectrum of the hydrophilic top phase of the PGMO formulation. The water peak 
at 4.7 ppm has been cut off. 
 The spectra indicate that the top phases of both samples contain almost no water and consist mostly 
of hydrophobic compounds such as the olive, MCT and sesame oil. The bottom phase contains water, 
propylene glycol and polysorbate 80.  
 
 
 
Figure 40. The figure shows the 2H spectrum of the GMO formulation top phase. 
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Figure 41. The figure shows the 2H spectrum of the GMO formulation bottom phase. 
The hydrophobic top phase of the PGMO formulation could not dissolve the added deuterium. It 
became distributed into different compartments that gave rise to the peaks at varying ppm values in 
the spectrum since the D2O encountered different chemical environments.  
 
Figure 42. The figure shows the 
2
H spectrum of the PGMO formulation top phase. 
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Figure 43. The figure shows the 2H spectrum of the PGMO formulation bottom phase. 
When viewed in a microscope with a polarized light source, the bottom phase of the PGMO 
formulation shows anisotropic phase structure upon shearing, which disappears shortly afterwards. 
After less than one minute without stress the sample shows no anisotropic structure. Figure below 
shows the sample at 10x magnification. The white shining parts of the sample indicate that the 
structure is anisotropic. 
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Figure 44. Picture of the PGMO formulation bottom phase sample viewed under polarized light at 10x magnification. 
It appears that all the samples are isotropic and the bottom phase of the PGMO formulation 
becomes anisotropic for a short while upon shearing using a single stroke from a spatula. 
Results from consumer study 
The results from the consumer study can be found in table 7 below.  A more detailed evaluation can 
be found in appendix 5. 
Table 7. Summary of the results from the graded questions in the questionnaire handed out to the participants. 
Question Mean score of GMO 
formulation 
Mean score of PGMO 
formulation 
Ease of staring the pump (5 is 
the most difficult) 
3.1 3.4 
Ease of administering to nose 
(5 is the most difficult) 
1.4 2 
Beam shot feeling (5 is the 
most pleasant) 
3.85 4.47 
Product smell (5 is the most 
pleasant) 
3.33 3.5 
Product taste (5 is the most 
pleasant) 
2.69 2.5 
Irritating to nose (5 is the most 
irritating) 
1.5 1.25 
Irritating to throat (5 is the 2.0 1.1 
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most irritating) 
Caring to the nose (5 is the 
most caring feeling) 
3.65 3.5 
Barrier forming (5 is the 
strongest barrier feeling) 
2.8 2.65 
Dripping out of nose (5 is the 
most dripping out of nose) 
2.9 2.55 
Likelihood to start using (5 is 
the most likely to start using 
2.3 2.5 
Likelihood to recommend (5 is 
the most likely to recommend) 
3.1 2.85 
 
Most of the scores for the two formulations are fairly similar. The pump is more difficult to get going 
initially with the PGMO formulation compared to the GMO formulation. This is probably due to the 
PGMO formulation having a higher viscosity than the GMO formulation. 
It appears that the problem with irritation in the throat has been solved with the PGMO formulation.  
The barrier and caring feeling is less prevalent for the PGMO formulation. This might be because the 
total feeling of having a product in the nose is less prevalent with the PGMO formulation.  
 A slightly less amount of the PGMO formulation is dripping out of the nose compared to the GMO 
formulation. This is likely because the PGMO formulation has a higher viscosity than the GMO 
formulation.  
Conclusions 
The results indicate that the GMO and PGMO formulations have very similar physical chemical 
properties in most cases. 
The problems with crystallization and phase separation at lower temperatures with the GMO 
formulation have been eliminated, probably due to the polydispersity of PGMO, which makes it a 
much less crystalline material that GMO. According to the product evaluation, the PGMO formulation 
is significantly less irritating to the throat compared to the GMO formulation. This is probably linked 
to the fact that it absorbs less water from the surrounding environment than the GMO formulation. 
 The PGMO formulation can tolerate a higher water content before phase separating than the GMO 
formulation.  
The PGMO formulation has a higher viscosity, which in combination with the new five-hole pump 
leads to a difficulty in getting the pump to start. However it seems to lead to less dripping out from 
the nose. 
Both products show quite strong mucoadhesion. The PGMO formulation shows slightly less 
spreadability on a hydrophilic surface. It spreads more slowly due to having a higher viscosity. 
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Future work 
 
In the future it would be interesting to study for how long the nasal oils stay in the nose. For an 
effective product the duration should be at least a few hours. The turnover rate in the nose is only 
10-15 minutes. 
When put on a water-rich surface, the PGMO formulation phase separates, and a thick hydrophilic 
phase that becomes anisotropic upon shearing forms closest to the surface. It could be of interest to 
study how this affects staying power inside the nose. 
The method for measuring mucoadhesion seems a bit unpredictable. A better method for measuring 
this property in vitro would be desirable.  
Looking more specifically at what interactions constitute mucoadhesion could be of use when 
designing products that should adhere to a mucus rich surface. 
Making a full clinical study where the effect against allergy and how the product is experienced is 
evaluated for the two formulations is a good way to verify that the physical chemical properties can 
translate to how the product is received by real consumers.   
Acknowledgements 
 
I would like to thank my Supervisor Birgitta Svensson for her support and guidance, all the personnel 
at Bioglan AB, Göran Carlström for helping me with the NMR spectroscopy experiments, Johan 
Engblom at Malmö Högskola for assisting me with the water activity measurements and Marie 
Wahlgren for showing me how to make mucoadhesion and surface tension measurements as well as 
giving valuable advice. 
I would like to thank the 40 volunteers who tried the products out and filled out the questionnaire.   
References 
 
[1] Aulton M, Taylor G. Aulton’s Pharmaceutics – The design and manufacture of medicines. Churchill 
Livingstone Elsevier 2013; 370,390-391. 
[2] Hildenbrand T, Weber R, Brehmer D. Rhinitis sicca, dry nose and atrophic rhinitis: a review of the 
literature. Eur Arch Otorhinolaryngol 2011; 268:17-26. 
[3] Skoner D. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. J 
Allergy Clin Immunol 2001 Vol. 108, number 1. 
[4] Acharya D, Hartley P. Progress in microemulsion characterization. Current Opinion in Colloid & 
Interface Science  2012; 17: 274–280. 
44 
 
[5] Andersson M, Greiff L, Wollmer P. Nasal treatment with a microemulsion reduces allergen 
challenge-induced symptoms and signs of allergic rhinitis. Acta Otolaryngologica 2008; 128: 666-669. 
[6] Andersson M, Greiff L, Wollmer P. Effects of a topical microemulsion in house dust mite allergic 
rhinitis. Basic Clin Pharmacol Toxicol 2011; 108: 146-148. 
[7] A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, 
controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares 
study). Ojeda et al. Allergy, Asthma & Clinical Immunology 2013, 9:32. 
[8] Harkema J, Carey S, Wagner J. The Nose Revisited: A Brief Review of the Comparative Structure, 
Function, and Toxicologic Pathology of the Nasal Epithelium. Toxicologic Pathology 2006; 34:252-269. 
[9] Smart J. The basics and underlying mechanisms of mucoadhesion. Advanced Drug Delivery 
Reviews 2005; 57:1556-1568. 
[10] Aulton M, Taylor G. Aulton’s Pharmaceutics – The design and manufacture of medicines. 
Churchill Livingstone Elsevier 2013; 370, 94-112. 
[11] http://www.escubed.co.uk/rheologyviscometry  Rheology (AN009) Oscillation and thixotropy 
document. Accessed 2015-02-25.        
[12] Coors E, et al. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. 
Ann Allergy Astmha Immunol. 2005; 95:593-599.  
[13] Fiume M, et al. Safety Assessment of Propylene Glycol. Tripropylene Glycol, and PPGs as Used in 
Cosmetics. International Journal of Toxicology 2012; 31:2455-2605. 
[14]  http://www.surface-tension.org/news/61.html Kino, accessed 2015-03-03. 
[15] http://www.omega.com/temperature/z/pdf/z103.pdf Equilibrium ReIative Humidity, Saturated 
SaIt Solutions, Omega, accessed 2015-0303.  
[16] https://www.dynesonline.com/visc_table.html Dynesonline Viscosity Table, accessed 2015-03-
13. 
[17] Basit A, et al. The Effect of Polyethylene Glycol 400 on Gastrointestinal Transit: Implications for 
the Formulations of Poorly-Water Soluble Drugs. Pharmaceutical Research 2001;Vol. 18, No. 8. 
[18] http://www.veganbaking.net/articles/tools/fat-and-oil-melt-point-temperatures Vegan Baking, 
accessed 2015-03-25 
[19] Keeler J. Understanding NMR Spectroscopy – Second Edition. Wiley 2010; 47-52.   
[20] http://chem.ch.huji.ac.il/nmr/techniques/1d/pulseq.htm#grad The NMR lab, institute of 
chemistry, Hebrew university, accessed 2015-04-23. 
[21] Stilbs P, Moseley M. Fourier Transform NMR Self-Diffusion Measurements on Microemulsions. 
Journal of Magnetic Resonance 1980; Vol 40, 401-404.  
45 
 
[22] Guéring P, Lindman B. Droplet and Bicontinuous Structures in Microemulsions from 
Multicomponent Self-Diffusion Measurements. Langmuir 1985; Vol. 1 No. 4, 464-468. 
[23] Lindman B, et al. Translational Diffusion and Solution Structure of Microemulsions. Journal of 
Physical Chemistry 1980; Vol. 84, 2485-2490.  
[24] Ivarsson D, Wahlgren M. Comparison of in vitro methods of measuring mucoadhesion: 
Ellipsometry, tensile strength and rheological measurements. Colloids and Surfaces B: Biointerfaces 
2012; Vol. 92, 353-359. 
[25] Nilsson M. The DOSY Toolbox: A new tool for processing PFG NMR diffusion data. Journal of 
Magnetic Resonance 2009; Vol. 200, 296-302.     
[26] Holz M, Heil S, Sacco A. Temperature-dependent self-diffusion coefficients of water and six 
selected molecular liquids for calibration in accurate 1H NMR PFG measurements. 
[27] Svensson B, Olsson U, Alexandridis P. Self-Assembly of Block Copolymers in Selective Solvents: 
Influence of Relative Block Size on Phase Behavior. Langmuir 2000; Vol 16, 6839-6846. 
[28] Mesa C, Khan A, Fontell K, Lindman B. Phase Diagrams and NMR Studies of Some Ternary 
Sodium Deoxycholate-Surfactant-Water Systems. Journal of Colloid and Interface Science 1985; Vol 
103, No. 2, 373-391. 
[29] Example ternary phase diagram 
http://upload.wikimedia.org/wikipedia/en/6/61/TernaryExample.svg 
[30] Illustration of amphiphile aggregation 
http://upload.wikimedia.org/wikipedia/en/a/a0/Lyotropic1.jpg 
[31] Ekelund K. Lipid bilayers versus monolayers – Sponge phases and skin lipid domains. Lund 
university 2000; 3-13. 
[32] Chemical shifts of different solvents. 
http://www.chem.ucla.edu/~webspectra/NotesOnSolvents.html 
[33] Aulton M, Taylor G. Aulton’s Pharmaceutics – The design and manufacture of medicines. 
Churchill Livingstone Elsevier 2013; 370,49-51. 
[34] Gizurarson S. The Effect of Cilia and the Mucociliary Clearance on Successful Drug Delivery. 
Biological and Pharmaceutical Bulletin 2015; 38, 497-506. 
 
 
 
46 
 
Appendix 
1. DSC run conditions 
 
 
Table 8. Summary for the run configurations of the DSC measurements done at Bioglan AB. 
Sample name Cooling/heating rate Sample weight Temperature program 
Blox4 GMO run 1 10 °C / min 9.94 mg +40°C to -40 °C to +40 °C 
Blox4 GMO run 2 10 °C / min 9.07 mg +40°C to -40 °C to +40 °C 
Blox4 GMO run 3 5 °C / min 11.19 mg +40°C to -40 °C to +40 °C 
Blox4 GMO run 4 5 °C / min 11.48 mg +40°C to -40 °C to +40 °C 
Blox4 GMO run 5 1 °C / min 12.33 mg +40°C to -40 °C to +40 °C 
Blox4 GMO run 6 1 °C / min 10.34 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 1 10 °C / min 11.73 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 2 10 °C / min 10.33 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 3 5 °C / min 12.34 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 4 5 °C / min 12.33 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 5 1 °C / min 11.28 mg +40°C to -40 °C to +40 °C 
Blox4 PGMO run 6 1 °C / min 11.21 mg +40°C to -40 °C to +40 °C 
 
 
Table 9. Summary for the run configurations of the DSC measurements done at LTH. 
Sample name Cooling/heating rate Sample weight Temperature program 
GMO Blox4 test run 1 5 °C / min 7.06 mg +40°C to -50 °C to +40 °C 
GMO Blox4 test run 2 1 °C / min 7.06 mg +40°C to -50 °C to +40 °C 
PGMO Blox4 test run 1 5 °C / min 6.519 mg +40°C to -50 °C to +40 °C 
PGMO Blox4 test run 2 1 °C / min 5.874 mg +40°C to -50 °C to +40 °C 
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2. Vegetable oil viscosity measurements 
All the vegetable oil viscosity measurements show that the samples exhibit a Newtonian behavior. 
 
Figure 45. The figure shows the viscosity of olive oil as a function of shear rate at low shear rates. 
 
Figure 46. The figure shows the viscosity of olive oil as a function of shear rate at high shear rates. 
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Figure 47. The figure shows the viscosity of sesame oil as a function of shear rate at low shear rates. 
 
Figure 48. . The figure shows the viscosity of sesame oil as a function of shear rate at high shear rates. 
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Figure 49. . The figure shows the viscosity of PGMO as a function of shear rate at low shear rates. 
 
Figure 50. The figure shows the viscosity of PGMO as a function of shear rate at high shear rates. 
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Figure 51. The figure shows the viscosity of MCT oil as a function of shear rate at low shear rates. The low points did not 
give a stable value due to the low viscosity of MCT oil. The missing points are due to negative received values, which 
have been discarded. 
 
Figure 52. The figure shows the viscosity of MCT oil as a function of shear rate at high shear rates. 
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3. DSC of different glycerol monooleates 
DSC runs were made on different types of glycerol monooleates to examine if a large crystallization 
peaks might lead to a product that is not as temperature stable. Below is a table that summarizes 
what compounds were tested and at what conditions. Depending on the state of the compounds at 
room temperature, the temperature program went either to 40 or 50°C. 
 
Table 10. Summary of the run conditions for the DSC excipient analysis done at Bioglan AB. 
Sample name Cooling/heating rate Sample weight Temperature program 
PGMO 5°C / min 10.50 mg +40°C to -50°C to +40°C 
GMO 5°C / min 11.79 mg +50°C to -50°C to +50°C 
PGMO3 5°C / min 9.12 mg +40°C to -50°C to +40°C 
PGMO2 5°C / min 13.42 mg +50°C to -50°C to +50°C 
PGMO2g 5°C / min 10.04 mg +50°C to -50°C to +50°C 
PGMO4 5°C / min 9.79 mg +40°C to -50°C to +40°C 
 
Below are figures that display the results from the DSC measurements. 
 
Figure 53. Plot of DSC data from the PGMO measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
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Figure 54. Plot of DSC data from the GMO measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
 
Figure 55. Plot of DSC data from the PGMO3 measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
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Figure 56. Plot of DSC data from the PGMO2 measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
 
Figure 57. Plot of DSC data from the PGMO2g measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
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Figure 58. Plot of DSC data from PGMO4 measurement, with a scan rate of 5°C/min, done at Bioglan AB. 
It appears that the variants with many glycerol groups attached to the carbohydrate chain make the 
compounds less liable to crystallize. PGMO and Hexaglyn 1-0V show no clear peaks from -50 to 40°C. 
The endset temperatures for the peak occurring at the highest temperature can be seen in Table X 
below. 
Table 11. Endset temperature for different glycerol monooleate variants. 
PGMO No clear peaks 
GMO 35.506°C 
PGMO3 -23.6°C  
PGMO -15.9°C 
PGMO2g -21.1°C 
PGMO4 No clear peaks 
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4. Consumer study questionnaire 
A product evaluation was performed with 40 participants. They received one of the formulations 
without knowing any details about what variant they were given. Below is the questionnaire that was 
handed out to each participant in the product evaluation together with a vial: 
 
Nasal product evaluation  
Welcome to a product evaluation of a nasal liquid that is used to form a barrier on the nasal mucosa 
to protect against pollen and house dust mites as well as to moisturize a dry nose. Please read the 
instructions and fill in the questionnaire. 
 
First, fill in some background information about yourself: 
Sex: 
⃝ Male 
⃝ Female 
⃝ Other:____________ 
 
Age: _______ years 
 
Do you suffer from eucalyptus or menthol allergy? If so it is unsuitable to participate in this study. 
 
Do you suffer from any allergies (if so, what allergies)? 
 
 
Do you use nasal products at other times (If so, what kind and how often)? 
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Have you ever experienced problems (not caused by allergies or having a cold) with your 
nasal mucosa due to having a dry nose (dryness, itching and/or irritation in the nose)?  
⃝  Never 
⃝  Sometimes (when?) 
____________________________________________________ 
⃝  Often (when?) 
____________________________________________________ 
Have you ever thought about the concept of dry nose symptoms before? 
⃝ Yes 
⃝ No 
 
 
Now it is time for the practical evaluation to start! 
Ensure that your nostrils are clear. If not, blow your nose. 
Keep the nasal product vial upright. 
Pump a few times into a paper or in the hand. 
Now take the nasal product, after you have ensured that it is pumping out a consistent amount of 
product, aim diagonally up the nostrils and pump once in each nostril. Try to avoid sniffing! Press 
gently on the outside of the nostril with your hand if it feels better.  
With the product in your nose, wait for ten minutes and then fill in the questionnaire by circling the 
number that corresponds to your experience of the product. 
How easy was it to pump compared to other nasal products you have tried? 
(Easy) 1 2 3 4 5               (Difficult) 
How easy was it to administer to the nose? 
(Easy) 1 2 3 4 5              (Difficult) 
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How did the product beam shot feel? 
(Unpleasant) 1 2 3 4 5             (Pleasant) 
 
 
Can you smell the product? 
⃝  No, I can’t 
⃝ Yes, and it is: 
(Unpleasant) 1 2 3 4 5              (Pleasant) 
And it smells like:_________________________________________ 
Can you taste the product? 
⃝  No, I can’t 
⃝ Yes, and it is: 
(Unpleasant) 1 2 3 4 5             (Pleasant) 
And it tastes like:_________________________________________ 
Do you feel any sensation in your nose from the product? 
⃝  No, I don’t 
⃝ Yes 
It feels like: _________________________________________ 
Does the product feel irritating in the nose? 
(No irritation)  1 2 3 4 5            (Strong irritation) 
 
Does the product feel irritating in the throat? 
(No irritation)  1 2 3 4 5            (Strong irritation) 
 
Do you experience the product as caring to a dry mucosa? 
(Not caring at all)    1   2 3 4 5          (Very caring) 
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Do you experience the product as forming a protective barrier in the nose? 
(No barrier feeling)     1    2                 3                   4                  5            (Strong barrier feeling) 
 
 
Is the product leaving the nostrils (dripping out of your nose)? 
(Not leaving the nose at all)    1              2             3              4                 5     (A lot of product dripping out) 
Would you consider starting to use this product? 
(Unlikely)    1              2             3              4                 5     (Likely) 
If you do, in what circumstances? 
 
_____________________________________________ 
_____________________________________________ 
Would you recommend this product to someone else? 
(Unlikely)    1              2             3              4                 5     (Likely) 
Why/why not? 
_____________________________________________ 
_____________________________________________ 
 
Good job answering the questions! 
 
If you have any comments you are very welcome to write them down below. We really appreciate 
your input. 
 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
__________________________________________________________________________________ 
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5. Assessment of product evaluation answers 
The answers are presented in the figures below. In all the diagrams in this section, the Y axis 
represents the number of people and the X axis the answer to the question or a grade from 1 to 5. 
 
Figure 59. The diagram shows the sex distribution of the participants. 
Most of the people participating in the evaluation were students aged 18-25. Among elderly it was 
more common to having heard about or suffering from a dry nasal mucosa. 
 
 
Figure 60. The diagram shows the age distribution of the participants. 
Many of the participants used nasal products as illustrated in the diagram below. 
0
5
10
15
20
25
Male Female
Sex distribution 
0
5
10
15
20
25
30
18-25 26-35 36-45 46-55 56-65 66+
Age distribution 
60 
 
 
Figure 61. The diagram shows how many of the participants uses nasal products. 
45 % of the participants suffered from allergies caused by pollen or animals. 
 
 
Figure 62. The diagram shows how many of the participants that suffer from allergies. 
Most participants had never thought about the concept of a dry nose before. Only 28 percent had 
thought about it. 
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Figure 63. The diagram shows how many people have thought about the concept of dry nose problems before. 
In some cases it was so hard to get the PGMO formulation pump going that the participants gave up 
thinking they had gotten a faulty device. 
The participants started the pumps by spraying a few times into a paper and then judging how 
difficult it was to get the pump started. A higher number means more difficult. The mean score for 
the GMO formulation in the evalutation was 3.1. 
 
Figure 64. The diagram shows how difficult it was to get the pump started. 
The mean score for starting the PGMO formulation pump was 3.4. 
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Figure 65. The diagram shows how difficult it was to get the pump started 
Ease of administering the product to the nose was not a clear question according to the participants. 
The figure below shows how easy it was to administer the product to the nose. 5 is the most difficult. 
The mean score for the GMO formulation was 1.4. 
 
Figure 66. The diagram shows how difficult it was to administer the GMO formulation to the nose. 
The mean score for ease of administering the PGMO formulation to the nose was 2.0. 
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Figure 67. The diagram shows how difficult it was to administer the PGMO formulation to the nose. 
The participants were asked how the beam shot felt. The GMO formulation nozzle had one centered 
hole giving a consistent hard jet. The PGMO formulation nozzle had five small holes leading to a more 
dispersed shot. The mean score for the GMO formulation beam shot feeling was 3.9.  
 
Figure 68. The diagram shows how the participants experienced the beam shot feeling of the GMO formulation. 
 
The mean score for the PGMO formulation was 4.5. 
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Figure 69. The diagram shows how the participants experienced the beam shot feeling of the PGMO formulation. 
The participants were asked if they could sense any smell from the nasal oil. 75 % of the participants 
could smell the GMO formulation. 30 % of the participants could smell the PGMO formulation. 
 
 
 
Figure 70. The diagram shows how many of the participants could smell the GMO formulation. 
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Figure 71. The diagram shows how many of the participants could smell the GMO formulation. 
The participants were asked how they experienced the smell. The GMO formulation smelt like 
linseed oil, lavender, menthol, eucalyptus, woody, härsken symaskinsolja. 
When asked how pleasant the smell was the participants rated the GMO formulation smell as 3.33 
where 5 is the most pleasant. The PGMO formulation was rated with the score 3.50. 
 
Figure 72. The diagram illustrates how pleasant the smell of the GMO formulation was. 
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Figure 73. The diagram illustrates how pleasant the smell of the PGMO formulation was. 
65 % of the participants could taste the GMO formulation. Only 10 % of the participants could taste 
the PGMO formulation. The taste of the GMO formulation was described as linseed oil, menthol, 
bubblegum or dry. The taste of the PGMO formulation was described as food oil. 
 
Figure 74. The diagram shows how many of the participants could taste the GMO formulation. 
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Figure 75. The diagram shows how many of the participants could taste the GMO formulation. 
When asked to evaluate how pleasant the taste was, where 5 is the most pleasant, the GMO 
formulation received the score 2.69 and the PGMO formulation 2.5, though this score comes from 
only two participants. 
 
Figure 76. The diagram shows how pleasant the taste of the GMO formulation was, according to the participants. 
The PGMO formulation taste was described as food oil. One participant felt that the taste was acrid.  
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Figure 77. The diagram shows how pleasant the taste of the PGMO formulation was, according to the participants. 
It seems that some people misinterpreted the question as irritating can mean many things. Most of 
the times it was made clear that a mild burning sensation was meant. When asked how irritating the 
product was inside the nose, where 5 is the most irritating the GMO formulation received the score 
1.5 and the PGMO formulation received the score 1.25. 
 
Figure 78. The diagram shows how irritating the GMO formulation was inside the nose, according to the participants. 
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Figure 79. The diagram shows how irritating the PGMO formulation was inside the nose, according to the participants. 
When asked how irritating the formulations were, where 5 is the most irritating, the GMO 
formulation received the score 2.0 and the PGMO formulation received the score 1.1. 
 
Figure 80. The diagram shows how irritating the GMO formulation is in the throat, according to the parcicipants. 
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Figure 81. The diagram shows how irritating the PGMO formulation is in the throat, according to the parcicipants. 
When asked how caring the product felt inside the nose, where 5 is the most caring the participants 
rated the GMO formulation with a score of 3.65 and the PGMO formulation with a score of 3.50. 
 
Figure 82. The diagram shows how caring the GMO formulation is, according to the participants. 
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Figure 83. The diagram shows how caring the GMO formulation is, according to the participants. 
Judging if the product was caring or barrier forming seemed like a difficult task. Here a little longer 
time than 10 minutes might have given more accurate answers. 
A score of 5 means that the product gives the strongest barrier feeling. The GMO formulation 
received a score of 2.80 and the PGMO formulation received a score of 2.65. 
 
Figure 84. The diagram shows how strong the barrier feeling of the GMO formulation was, according to the participants. 
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Figure 85. The diagram shows how strong the barrier feeling of the PGMO formulation was, according to the participants. 
The PGMO formulation had a lower score, meaning less dripping, that the GMO formulation probably 
due to having a higher viscosity. When asked how much of the product dripped out of the nose 
where 5 is a lot dripping out and 1 is no product dripping out at all the GMO formulation received a 
score of 2.90 and the PGMO formulation received a score of 2.55. 
 
Figure 86. The diagram shows how much of the GMO formulation was dripping out of the nose, according to the 
participants. 
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Figure 87. The diagram shows how much of the PGMO formulation was dripping out of the nose, according to the 
participants. 
 
Some sensations felt in the nose from the GMO formulation were: blocking, oily, smoother, 
rehydrated, not as blocked running moisture, tingling.  
Some sensations felt in the nose from the PGMO formulation were: blocked, itchy, oily, wet, runny 
nose, sticky. 
Many users felt that there was something in their nose and they wanted to get it out to have clear 
nostrils again. 
The PGMO formulation had the comments: “Took too much because I could not feel it.” “No effect, 
nose feels soft afterwards.” “It was annoying with oil in the nose.” “A nice smell would be better.” “I 
wanted to blow my nose.” “It is good to feel something inside your nose, like you have accomplished 
something when you take it.” 
The GMO formulation had the comments: “It was irritating to the nose and throat.” “Nice smell.” 
“The nose was running a little.” “After 10 minutes I felt a burning sensation in throat.” “It seems to 
be useless.” “It drips out of the nose.” 
When asked if they would consider using the product where 5 is most likely, the participants rated 
the GMO formulation with the score 2.3 and the PGMO formulation with the score 2.5. 
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Figure 88. The diagram shows how likely it is that the participants start using the GMO formulation. 
 
Figure 89. The diagram shows how likely it is that the participants start using the PGMO formulation. 
When asked how likely it would be for the participants recommending the product to someone else, 
where 5 is most likely, the participants rated the GMO formulation with the score 3.1and the PGMO 
formulation with the score 2.85. 
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Figure 90. The diagram shows how likely it is that the participants recommend the GMO formulation. 
 
Figure 91. The diagram shows how likely it is that the participants recommend the PGMO formulation. 
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